Inovio Pharmaceuticals, Inc. Common Stock Nasdaq Global Select
Open: $3.9 High: $3.955 Low: $3.465 Close: $3.89
Range: 2022-01-24 - 2022-01-25
Market: Extended-hours
Inovio Pharmaceuticals, Inc. Common Stock 660 West Germantown Pike Plymouth Meeting PA, 19462
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
  • CEO: J. Joseph Kim
  • Employees: 278
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
INO News
Latest news about the INO